QQ客服 官方微博 反馈留言

	Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression
	Kaltenecker Doris; Themanns Madeleine; Mueller Kristina M; Spirk Katrin; Suske Tobias; Merkel Olaf; Kenner Lukas; Luís Andreia; Kozlov Andrey; Haybaeck Johannes
	2018
关键词	Hepatic lipid metabolism Liver Liver cancer NAFLD
ISSN号	1096-0023
DOI	10.1016/j.cyto.2018.10.010
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6351875
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Kaltenecker Doris,Themanns Madeleine,Mueller Kristina M,et al. Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression[J],2018.
APA	Kaltenecker Doris.,Themanns Madeleine.,Mueller Kristina M.,Spirk Katrin.,Suske Tobias.,...&Moriggl Richard.(2018).Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression..
MLA	Kaltenecker Doris,et al."Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression".(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。